GP5 – The Invisible Innovation That Could Save Lives (and Budgets)
Some technologies you can touch. Others you need a microscope to see.And then there are those that quietly change everything — without anyone noticing. GP5 is one of them. The …
News
Distribution matters!
🤖 Distribution matters!With GP5, it’s not just about what’s on the surface – it’s how it’s distributed. Spacing between particles must be consistent to ensure optimal immune response suppression. That’s …
Do you want to see GP5?
🔬 Do you want to see GP5?Even though GP5 particles are only 20–40 µm in diameter, you *can* see them – and we’ve captured it on camera. Here’s a close-up …
Live from Folkemødet
🔵 LIVE FRA FOLKEMØDET: NÅR TEKNOLOGI OG SUNDHED MØDESVi er til stede på Folkemødet – hvor innovation og sundhedspolitik møder virkelige løsninger.I dialogen med beslutningstagere og aktører i sundhedsvæsenet stiller …
GP5 Technology Highlights
Successful in vitro tests in Norway at our Glucare consortium partner ZPBig news from the lab!We’re excited to share that our in vitro tests at Zimmer & Peacock (ZP) in …
How does GP5 works?
People sometimes ask how our product, GP5, works. Here’s a quick explainer – enjoy!
New CGM preparation
We’ve arrived at Zimmer and Peacock, our Glucare partner, to conduct in vitro testing of the new implantable CGM in preparation for our upcoming preclinical trial.
SIT promotion video
A video about ourself and how our technology works. The video includes statements from independent experts endorsing GP5, Safe Implant Technology’s proprietary imune suppressing technology. It actually works. Enjoy!
A visit from the mayor
Safe Implant had the honor of hosting Karina Vincentz, the Mayor of Odsherred Kommune, and Tina Charlotte Frederiksen, Business Manager Odsherred Kommune, for a distinguished visit yesterday. They were enthusiastic …
Safe Implant Technology’s first preclinical trials
Safe Implant Technology has taken the first step towards MDR approval of our patented product GP5. Yesterday medical device implants were implanted, and preclinical trial will continue for the next 9 weeks to evaluate safety and efficacy of biocompatibility.
GLUCARE Eurostars project
The GLUCARE consortium, which Safe Implant Technology is part of, has been awarded with funding from EUROSTARS to execute the ~€1,3M GLUCARE project aiming to develop a first-in-class implantable biosensor for continuous glucose monitoring (CGM) with long-term tolerability that will allow diabetic patients to benefit from accurate real-time blood glucose measurements for more effective diabetes management.